Speakers' Portal WIP18 CME Disclosure Form Results
|
|
|
- Austen Webster
- 5 years ago
- Views:
Transcription
1 ' Portal WIP18 CME Disclosure Form Results Last Name First Name Roles Relationships Company Name Aasvang Eske Agur Anne Allegri Massimo Argoff Charles Poster/Oral Presenter Assis Fabricio Basbaum Allan Benzon Honorio T. Berkman Alan Merck Angelini Mundipharma Eli Lilly Honoraria/ Expenses Consulting/ Advisory Board Daiichi Sankyo AstraZeneca Funded Jazz Amgen Royalties/ Patent Stock Options Ownership/ Equity Position Employee Other Off Label Product Use Academy of Excellence Canada Anatomy Faculty own stock Depomed own stock Purdue Pharma Quest Diagnostics Vertex Pharmaceuticals Collegium BDSI TEVA Lilly Neurona Coda Biotherapeutics
2 Bhatia Anuj Bosscher Hemmo Bruce Julie Poster/Oral Presenter Brummett Chad Recro Pharma Inc; Heron Therapeutics Buford Don Conmed Linvatec Terason Calodney Aaron Fuji Sonosite IOF Celling Trice Medical Orthotalk, Inc. Konica Minolta Stryker Caplan Chang-Chien Arnold George Cheatle Martin Compton Peggy Darnall Beth Davis Karen Day Miles De Andrés De Andres José Javier Ares de Meij Nelleke Dickenson Anthony Scientific/Education Dik Wim Dooley Colette Errico JP Fox Gatchel Ira Robert Gerdesmeyer Ludger Gofeld Michael Scientific/Education Gulati Amit Apex Biologix AIS Epimed International Teva electrocore, LLC. Palladian Health Care West Coast Spine Restoration Bioness SPR Therapeutics Board Member and Shareholder
3 Hartrick Haumann Craig Johan Scientific/Education Board of Directors Hayek Salim Hegarty Dominic Scientific/Education Hernández- B. Carolina Porras Huygen Frank Jamison Robert Jimenez Jo Juan Miguel Daehyun Joosten Bert Kallewaard Jan Willem Kapural Leonardo Krakauer Eric Lambru Lavand'homme Giorgio Patricia Liem Liong Mackey Sean Mavrocordatos Philippe McMahon Stephen Boston Scientific Bioness Neurometrix St. Jude Medical Boston Scientific Neuros SPR Therapeutics Halyard Saluda Stimwave Nalu Gimer Medical Best Doctors Aurora Diagnostics Path AI Strata Diagnostics Regeneron Ono Pharma Mekhail Nagy Flowonix Boston Scientific
4 Poster/Oral Presenter Mesoblast Neuros Nuvectra Morlion Bart Murphy Matthew Nicol Andrea e Carl Ottestad Einar Palmisani Stefano Peppin John Plancarte Primorac Ricardo Dragan Puylaert Martine Racz Gabor Scientific/Education Rajagopal M.R. Rathmell James Reid M. Cary Reina Miguel Angel Simon Bruce Staats Peter Scientific/Education Board of Directors Mundipharma TEVA Boehringer-Ingelheim Bioness Ferring Pharmaceuticals Janssen Pharmaceuticals Vyera Pharmaceuticals Epimed Mainstay Medical electrocore Neurogesx A large number of nonopioids related to chronic pain treatment as either on or off-label I may be presenting animal and pilot clinical data on investigational models I may be presenting animal and pilot clinical data on investigational models stimulation. products stimulation. products stimulation. products Boston Scientific stimulation. products
5 stimulation. products stimulation. products Vertos Medical stimulation. products stimulation. products Steegers Monique Stinson Jennifer Poster/Oral Presenter Stogicza Agnes Stojanovic Milan Szadek Karolina Vadalouca Athina Van Boxem Koen Van Eerd Maarten van Kleef Maarten Scientific/Education van Kuijk Sander van Rooij rbert van Zundert Jan Scientific/Education Varrassi Giustino Vissers Kris Scientific/Education Walsh Donna EFNA receives funding from a consortia of industry partners. However, these are not personal relationships. Wells Chris
Neuromodulation Editorial Board Conflict of Interest Disclosures
Neuromodulation Editorial Board Conflict of Interest Disclosures Compensation Levels (1) $500 - $5,000 (2) $5,001- $20,000 (3) > $20,000 Kenneth Aló, MD: Nothing to Disclose Jeff Arle, MD, PhD, FAANS Consultant/Advisory
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
Method of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
2,500,000 Shares. Common Stock
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-201841 Prospectus Supplement No. 15 to Prospectus dated February 26, 2015 2,500,000 Shares Common Stock This Prospectus Supplement No. 15
Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
Annual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
Early Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
Previous Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
TRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
Virginia Tech Department of Recreational Sports Intramural Sports Table Tennis Singles
Mens Comp 1 Alex Tsai (571) 314 6769 alext5@vt.edu 2 Anthony Peluso (757) 620 0659 anthp98@vt.edu 2 Austin Skeens (276) 219 5926 saustin8@vt.edu Ben Spickard (919) 817 7000 benspickard@gmail.com 2 Brad
University of Connecticut
University of Connecticut Office of Technology Commercialization (OTC) Commercialization - Technology Transfer at UConn Why Commercialize? Inventor: To see invention used To obtain research support and
The Role of Patients in Transitions of Care
Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,
ELI WHITNEY ADVISORY COMMITTEE of Connecticut Innovations, Incorporated Minutes Regular Meeting Thursday, May 2, 2013
ELI WHITNEY ADVISORY COMMITTEE of Connecticut Innovations, Incorporated Minutes Regular Meeting Thursday, May 2, 2013 A regular meeting of the Eli Whitney Advisory Committee of Connecticut Innovations,
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
Page 1 of REVIEW HEARING MANDY C PALMER AND JASON A PALMER PALMER, MANDY CHRISTINE PALMER, JASON ARLAN STATE OF WASHINGTON, NFN
1. 04-3-00489-6 REVIEW HEARING MANDY C PALMER AND JASON A PALMER PALMER, MANDY CHRISTINE PALMER, JASON ARLAN STATE OF WASHINGTON, NFN 2. 08-3-00346-9 PRESENTATION OF FINAL ORDER BILLIE J MILLER AND TERRY
1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner
Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:
One of UC s greatest strengths is its long history of discovery; innovation that truly transforms our lives. Under our new strategic vision, UC 21,
One of UC s greatest strengths is its long history of discovery; innovation that truly transforms our lives. Under our new strategic vision, UC 21, we are working even more aggressively to build research
People. Move PHARMA COMPANIES. on the. Abbott Nutrition International. AstraZeneca. Axcan Pharma. Berlex. Bristol-Myers Squibb
People on the Move PHARMA COMPANIES Gary Schmid Abbott Nutrition International Crawford Wright AstraZeneca Abbott Nutrition International Gary Schmid, formerly Director of Marketing, Primary Care Division,
Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
Commercialization Workshop Series Commercialization Pathways. April 2, 2015
Commercialization Workshop Series Commercialization Pathways April 2, 2015 Commercialization Workshop Series Commercialization Pathways Commercialization Options Parasight Seikowave Dean Harvey Eric Hauck
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
FEDERAL RESERVE BANK OF SAN FRANCISCO 12TH DISTRICT STATE MEMBER BANKS AS OF: 6/30/17
ARIZONA PHOENIX WESTERN ALLIANCE BANK CM 0 3138146 MR. ROBERT G. SARVER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER CALIFORNIA SANTA ROSA ALTAPACIFIC BANK CM 0 3453737 MR. CHARLES O. HALL, PRESIDENT, CHIEF EXECUTIVE
Corporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
Managing Conflict of Interest
Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians
FEDERAL RESERVE BANK OF SAN FRANCISCO 12TH DISTRICT STATE MEMBER BANKS
ARIZONA PHOENIX 3138146 WESTERN ALLIANCE BANK MR. ROBERT G. SARVER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER CALIFORNIA SANTA ROSA 3453737 ALTAPACIFIC BANK MR. CHARLES O. HALL, PRESIDENT AND CHIEF EXECUTIVE
ANNUAL GENERAL MEETING OF ARGENX SE EXPLANATORY NOTES
ANNUAL GENERAL MEETING OF ARGENX SE EXPLANATORY NOTES The following items on the agenda of the meeting shall be discussed and/or put to a vote. The numbers in the list correspond to the numbers on the
Program as of November 1, 2016
Monday, November 14, 2016 Registration Open 11:30 am - 3:30 pm Program as of November 1, 2016 IPCC Business Meeting & Working Luncheon 12:00 pm 3:15 pm *Open to IP Counsels Committee company members only
Say on Pay at the Life Sciences 80 A Final Look at 2015 Before we turn our full attention to the
January 11, 2016 compensia.com Say on Pay at the Life Sciences 80 A Final Look at Before we turn our full attention to the upcoming 2016 proxy season, it s time to take a final look at the results for
September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
Disclosures of Relevant Financial Relationships
Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence
Mass Team 1 Mass Team 2 Mass Team 3
11/29-11/30 # 12/6-12/7 # 12/13-12/14 # SAT 5:00 PM Christopher, Michael H SAT 5:00 Branch, Pam H SAT 5:00 Butler, Virginia H Farney, Carol C Connolly, Alice C Cabral, Kathy C Hannan, Ann C+ Cutter, Ray
Triton Technology Fund
Triton Technology Fund Presentation to Dean s Engineering Council March 22, 2013 Generate Returns for LPs/GPs Motivation for Fund Catalyze translation of UCSD discoveries for the benefit of society Enable
Best Lawyers in America Recognizes 78 Lathrop Gage Attorneys
Best Lawyers in America Recognizes 78 Lathrop Gage Attorneys August 16, 2016 KANSAS CITY, Mo. (Aug. 16, 2016) - Best Lawyers in America today announced its 2017 rankings which include nine Lawyers of the
CORRECTED 1/27/2018 7/29/ , , /10/2018 5,657.04
CORRECTED X 1/27/ 7/29/ 13,000.00 13,000.00 5,657.04 9/10/ ATTACHMENT TO RAMSEY COUNTY CAMPAIGN FINANCIAL REPORT FORM FOR THE PERIOD JANUARY 27, THROUGH JULY 29,, DUE AUGUST 3,, FOR THE ROBINS KAPLAN MINNESOTA
6/9/2017 Portage County Ohio. Court Schedule Report Hearing Date from: 6/9/2017 to 6/23/2017 MAGISTRATE TIMOTHY D LUDICK. Friday, June 9, 2017
1 Friday, June 9, 2017 1:30 pm 2007DR00555 FOX, AMBER D vs FOX, SCOTT W STATUS HEARING DR COURTROOM 3 FOX, AMBER D TERILLA, JOHN ANTHONY FOX, SCOTT W KOHLI, S KIM 2 Monday, June 12, 2017 9:00 am 2013DR00106
Experiences of an aspiring young scientist-entrepreneur
Experiences of an aspiring young scientist-entrepreneur Francis W. Hunter Auckland Cancer Society Research Centre Spark Entrepreneurship Challenge Mesopharm Therapeutics, Inc. 5 May 2014 Background Auckland
Highland County, Ohio Court Schedule Report from: 12/12/2016 to 12/30/2016 MAGISTRATE CYNTHIA WILLIAMS Monday, December 12, 2016
Monday, December 12, 2016 1 04DR0111 OSBORN, TONY vs Final hearing Plaintiff OSBORN, TONY Armintrout, George William Plaintiff OSBORN, LOUISE Stroop, Richele Marie 10:00 am 16DS0197 RUMER, KRISTINE ELIZABETH
Academic Technology Licensing & the America Invents Act
Academic Technology Licensing & the America Invents Act Eric Gosink, Ph.D. Senior Licensing Officer November 1 st, 2013 University of California San Diego Expertise and Resources Scripps Inst. Oceanography,
LYCOMING COUNTY COURT OF COMMON PLEAS
CP-41-CR-0001920-2016 Allabach, Matthew Royce CP-41-CR-0001317-2018 Ardrey, Mackenzie Taylor cons w/ Vaughn & Lazorka CP-41-CR-0001273-2018 Bailey, Andrew W. CP-41-CR-0001231-2018 Baskin, Mark Allen CP-41-CR-0002072-2017
The 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors
The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors Conference Program Tuesday October 17, 2017 Hilton Boston Dedham TABLE OF CONTENTS SECTION PAGE OUR PARTNERS Thank
Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
Partnering with Universities for Deal Flow
Partnering with Universities for Deal Flow How working with your local university can lead you to the next Google! Welcome! January 14, 2015 Use chat to submit questions Yes, you ll get the slides We re
Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors
Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors David B Allison Dr. Allison has received personal payments or promises for same from: American Society for Nutrition;
Eucharistic Minister Reader Usher Altar Server. 1 st R = Patricia McEnery 2 nd R = Lucas Acosta-Morales
August 4 August 5: Eighteenth Sunday in Ordinary Time Donna Campbell Phyllis Connelly Georganna Krivonak Paul Krivonak 1 st R = Patricia McEnery 2 nd R = Lucas Acosta-Morales Dorie Borowski Andrew Ahern
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
Cover Letter. Ms. Gallo GLC201 March
Cover Letter Ms. Gallo GLC201 March 30 2015 Today s Goal I will be able to understand the importance of a cover letter and be able to create one in the computer lab! Brainstorm: Think/Pair/Share What is
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
People. Move. on the. Pierre Benjamin, MD, has been appointed Project Leader, Zavesca, at Actelion Pharmaceuticals.
Pierre Gendron Guy Le Houillier Jocelyn Marquis Actelion Viken Paragamian Amgen Canada Stephane Langevin Pierre Benjamin Actelion Dr. Martin Holroyde Altana Pharma Lita Stewart Amgen Canada People on the
Special Executive Report
Special Executive Report S-6532 WEEKLY POSTING MEMBERSHIP/SHARE SALES AND TRANSFERS Members having any information regarding the transferees listed below are requested to communicate the same to the Shareholder
CIVIL NON JURY February 25, :00AM HONORABLE G. CAREY NELSON, PRESIDING CAUSE OF ACTION
1. CONTRACT ACCOUNT RETAIL EMPLOYEES CREDIT UNION SCOTT M STEVENS LESLIE M VELTRIE 2. PETITION FOR MODIFICATION OF CUSTODY JASON A STANFIELD DOROTHY N PADGETT CHRISTINA STAHL 3. MODIFI-CUSTODY PAUL E ROWELL
Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio
HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company
Inclusion Women at the Forefront of STEM
Innovation and Inclusion Women at the Forefront of STEM Hosted by the Association for Women in Science SPONSORSHIP Innovation and Inclusion: Women at the Forefront of STEM The Association for Women in
Taking a Deep Breath in a Busy World
Taking a Deep Breath in a Busy World Monique Jericho MD, FRCP(C) April Elliott MD, FRCP(C), FSAHM Child and Adolescent Psychiatrist CMD, Calgary Eating Disorder Program Chief, Division of Adolescent Medicine
FEDERAL RESERVE BANK OF SAN FRANCISCO 12TH DISTRICT STATE MEMBER BANKS
AS OF: 9/3/17 ARIZONA PHOENIX 3138146 WESTERN ALLIANCE BANK MR. ROBERT G. SARVER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER CALIFORNIA SANTA ROSA 3453737 ALTAPACIFIC BANK MR. CHARLES O. HALL, CHIEF EXECUTIVE
WORKING GROUP 3&5: PUBLIC-PRIVATE PARTNERSHIP
WORKING GROUP 3&5: PUBLIC-PRIVATE PARTNERSHIP Susan Tansey / Pirkko Lepola Chair / Co-Chair WG 3&5 1 Role: Facilitate communication between industry and networks Gather examples of good practice from Networks
SPEAKER BIOGRAPHIES. Sarah Abbas
SPEAKER BIOGRAPHIES Sarah Abbas Sarah Abbas currently supports global medical education through collaboration with Pfizer Country Offices. She developed and managed the WW Investigator Initiated Research
Institutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant
Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,
Successful Science Communication
SUB Hamburg A 2011/11094 Successful Science Communication Telling It Like It Is Edited by DAVID J. BENNETT Delft University of Technology, The Netherlands RICHARD C. JENNINGS University of Cambridge, UK
TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION
utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?
CIVIL NON JURY September 24, :00AM HONORABLE SCOTT SMITH, PRESIDING CAUSE OF ACTION
1. ADOPTIONS P LESLIE VAUGHAN SIMMONS D 2. MOTION FOR CONTEMPT MELANIE CANTRELL BARRY B GREENE RANDY CANTRELL JASON A JOHNSON 3. ALICIA LATOYA LONG PRO SE KENNETH LEO BELCHER TWO CERTIFICATES ZACHARY PRITCHARD
Technology Transfer for Small and Medium Sized Enterprises
International Conference on Technology Transfer for Small and Medium Sized Enterprises Organized by the International Intellectual Property Institute (IIPI) Sponsored by the World Intellectual Property
e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)
e-care Living Lab e-care Living Lab in Rhône-Alpes Region e-care got the Living Lab label in 2010 from ENoLL e-care Living Lab objectives (1/2) To promote the Living Lab approach in the healthcare sector
TENOR CAPITAL PARTNERS. ESOP Leveraged Buyout Specialist,
TENOR CAPITAL PARTNERS ESOP Leveraged Buyout Specialist, Tenor Capital Partners, LLC (TCP) is the leading boutique investment bank in the southeast focused exclusively on advising, and acting as advocate
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
ELI WHITNEY ADVISORY COMMITTEE of Connecticut Innovations, Incorporated Minutes Regular Meeting Thursday, November 7, 2013
ELI WHITNEY ADVISORY COMMITTEE of Connecticut Innovations, Incorporated Minutes Regular Meeting Thursday, November 7, 2013 A regular meeting of the Eli Whitney Advisory Committee of Connecticut Innovations,
Annual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
Publisher/s: Oxford Medical Publications. Edition:? Date: January, 1984 ISBN 13: ISBN 10:
The following are Recommended Basic Texts for BCh.D. Students General Gross Anatomy Anatomy for Dental Students D. R. Johnson, W. J. Moore Publisher/s: Oxford Medical Publications? Date: January, 1984
Industry Insight. Obesity Treatment using. Neurostimulation. Technology Evolution & Patent Landscape. Deeper Insight.
Industry Insight Obesity Treatment using Neurostimulation Technology Evolution & Patent Landscape R Deeper Insight. Better Outcomes Introduction Neurostimulation for Obesity Treatment The incidence of
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of
TRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
The Netherlands Life Sciences Gateway to Europe
The Netherlands Life Sciences Gateway to Europe WHY FOREIGN LIFE SCIENCE COMPANIES INVEST IN THE NETHERLANDS Centrally located between Germany, France and the UK with a highly efficient (logistics) infrastructure
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event
BOARD OF EMPLOYEE LEASING COMPANIES. TELEPHONE CONFERENCE CALL MEETING MINUTES TUESDAY, AUGUST 21, :00 a.m. EST MEET-ME-NUMBER: (888)
TELEPHONE CONFERENCE CALL MEETING MINUTES TUESDAY, AUGUST 21, 2013 10:00 a.m. EST MEET-ME-NUMBER: (888) 670-3525 I. CALL TO ORDER The meeting was called to order at approximately 10:05 a.m. EST by Mr.
Kennedy Space Center Connecting with Mid-Atlantic Region Space Grant Consortia
Kennedy Space Center Connecting with Mid-Atlantic Region Space Grant Consortia Gregg Buckingham, EdD Connecting Marshall Space Flight Center with Mid-Atlantic Space Grant Consortia Marshall Space Flight
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
10:00 Reducing Complexity in Pharma Marc Philipp & Markus Hayek, Accenture. Session 1 Regulatory Updates Moderator: Jette Christensen, Novo Nordisk
Tuesday, 26 June 2018 20 Jun 2018 9:00 Welcome & Opening Remarks Introduction & PDA Appreciation Awards Falk Klar, PDA Europe Jette Christensen, Chair, Novo Nordisk Borke Van Belle, Chair, Janssen J&J
Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
Purpose of the summary
Summary of Expertise, Experience, and Affiliations and Interests Scientific Advisory Committee on Sciences and Clinical Pharmacology (SAC-PSCP) Purpose of the summary The following table summarizes the
Technology Transfer. Research Universities as Engines for Economic Development
Technology Transfer Research Universities as Engines for Economic Development Topics & Speakers 1. Technology Transfer Fundamentals Chip Hood (MUSC-FRD) 2. Technology Transfer in S.C. Chad Hardaway (USC
SPORTS MEDICINE: TECHNOLOGIES AND GLOBAL MARKETS
SPORTS MEDICINE: TECHNOLOGIES AND GLOBAL MARKETS HLC183A March 2015 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-061-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215